Introduction
The impact of NSAIDs on osseointegration remains controversial, with conflicting evidence from animal models and human clinical trials. The aim of the study was to investigate the association between the use of common Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and the risk of early dental implant failure in a large, real-world patient cohort.
Methods
This retrospective cohort study utilized an EHR database of 12,943 patients receiving 49,997 implants. Patients were divided into an NSAID group (n = 3133) and a non-NSAID control group (n = 9810). The primary outcome was early implant failure, defined as implant removal within six months of placement. Multivariable logistic regression models were used to calculate Odds Ratios (ORs) for failure, adjusting for patient age, gender, history of diabetes, and history of osteoporosis. Analyses were conducted at both the implant and patient levels.
Results
Patients in the NSAID group were significantly older (62.8 vs. 58.7 years, p < 0.0001) and had a higher prevalence of diabetes (22.0% vs. 16.7 %, p < 0.0001) and osteoporosis (11.0 % vs. 7.0 %, p < 0.0001). After adjusting for confounders, implant-level analysis showed that Ibuprofen use (OR 2.29; 95 % CI 1.48–3.55; p < 0.0001) and Naproxen use (OR 2.65; 95 % CI 1.22–5.75; p = 0.0137) were significantly associated with increased odds of early failure. At the patient level, the association remained highly significant for Ibuprofen (OR 2.87; 95 % CI 1.83–4.51; p < 0.0001), but not for Naproxen (p = 0.0689).
Conclusion
The use of Ibuprofen and, to a lesser extent, Naproxen, is associated with a significantly increased risk of early dental implant failure, independent of other patient risk factors. Clinicians should consider these findings when formulating post-operative analgesic plans, particularly for patients with complex medical histories.
扫码关注我们
求助内容:
应助结果提醒方式:
